期刊
CELL TRANSPLANTATION
卷 22, 期 3, 页码 423-436出版社
SAGE PUBLICATIONS INC
DOI: 10.3727/096368912X653246
关键词
Mesenchymal stem cells (MSCs); Migration; Insulin-like growth factor-1 (IGF-1); Acute kidney injury (AKI); Kidney repair
资金
- Research Training Network Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy
- European Community as part of the Framework program 6 [FP6 036097-2]
- European Community [223007]
- STAR-TREK project
Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据